Seroprevalence of Trypanosoma cruzi infection in blood donors (preliminary study);Seroprevalencia de la infección por Trypanosoma cruzi en donantes de sangre (estudio preliminar)

Enfermedades Emergentes

Volumn 7, Issue SUPPL. 1, 2005, Pages 40-42

  Barea, Luisa ^a   González, Rocío ^a   Bueno, Jose L ^a   Cañavate, Carmen ^a   Flores, María ^a   Rodriguez M ^a   Gárate, Teresa ^a   Castro, Emma ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b Centro de Donación de Sangre Cruz Roja   (Spain)

Author keywords

Chagas; Serodiagnosis; Transfusion

Indexed keywords

PROTOZOON ANTIBODY;

BLOOD DONOR; BLOOD TRANSFUSION; CHAGAS DISEASE; CONFERENCE PAPER; ENDEMIC DISEASE; EPIDEMIOLOGICAL DATA; HUMAN; INFECTION RISK; SEROPREVALENCE; SOUTH AND CENTRAL AMERICA; SPAIN; TRYPANOSOMA CRUZI;

EID: 21844469017     PISSN: 15754723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Shulman IA. Intervention strategies to reduce the risk of transfusion-transmitted Trypanosoma cruzi infection in the United States. Transfus Med Rev 1999;13:227-34.
2. Camargo ME. Fluorescent antibody test for the serodiagnosis of American trypanosomiasis. Technical modification employing preserved culture forms of Trypanosoma cruzi in a slide test. Rev Inst Med Trop Sao Paulo 1966;8:227-35.
3. Scott P, Pearce E, Natovitz P, et al. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes. J Immunol 1987;139:221-7.
4. Wendel S, Gonzaga AL. Chagas' disease and blood transfusion: a New World problem? Vox Sang 1993;64:1-12.
5. Wendel S. Transfusion-transmitted Chagas' disease. Curr Opin Hematol 1998;5:406-11.
6. López-Antuñano F, Rangel-Flores H, Ramos C. Diagnosis of Chagas' disease. Revista Latinoamericana de Microbiologia 2000;42:121-9.
7. Leiby DA, Lenes BA, Tibbals MA, et al. Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. N Engl J Med 1999;341:1237-9.
8. Brashear RJ, Winkler MA, Schur JD, et al. Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United States. I. Evaluation of the sensitivity and specificity of an enzyme immunoassay for detecting antibodies to T. cruzi. Transfusion 1995;35:213-8.
9. Wendel S. Transfusion-transmitted Chagas' disease. Curr Opin Hematol 1998;5:406-11.
10. Salles NA, Sabino EC, Cliquet MG, et al. Risk of exposure to Chagas' disease among seroreactive Brazilian blood donors. Transfusion 1996;36:969-73.
11. Umezawa ES, Bastos SF, Coura JR et al. An improved serodiagnostic test for Chagas' disease employing a mixture of Trypanosoma cruzi recombinant antigens. Transfusion 2003;43:91-7.
12. Umezawa ES, Bastos SF, Coura JR, et al. An improved serodiagnostic test for Chagas' disease employing a mixture of Trypanosoma cruzi recombinant antigens. Transfusion 2003;43:91-7.
13. Leiby DA, Herron RM, Jr, Read EJ, et al. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion 2002;42:549-55.
14. Leiby DA. Parasites: An emerging threat to blood safety. Blood therapies in Medicine 2003;4(1):5-10.
15. Alvarez M, Oyonarte S, Rodriguez PM, et al. Estimated risk of transfusion-transmitted viral infections in Spain. Transfusion 2002;42:994-8.
16. Busch MP, Kleinman SH, Jackson B, et al. Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors. Transfusion 2000;40:143-59.
17. Appleman MD, Shulman IA, Saxena S, et al. Use of a questionnaire to identify potential blood donors at risk for infection with Trypanosoma cruzi. Transfusion 1993;33:61-4.
18. Castro E, Bueno JL, Fresno M, and Gironés N. Photochemical treatment with methylene blue and light as weel as freezing of plasma avoids trypanosoma cruzi transmission by transfusion. Transfusion 44 (suppl). 2004.
19. Corash L. Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates. Vox Sang 1998;74 (Suppl 2):173-6.
20. Van Voorhis WC, Barrett LK, Eastman RT, et al. Trypanosoma cruzi inactivation in human platelet concentrates and plasma by a psoralen (amotosalen HCl) and long-wavelength UV. Antimicrob Agents Chemother 2003;47:475-9.
21. Corash L. Inactivation of viruses, bacteria, protozoa and leukocytes in platelet and red cell concentrates. Vox Sang 2000;78 (Suppl 2):205-10.
22. Moraes-Souza H, Bordin JO, Bardossy L, et al. Prevention of transfusion-associated Chagas' disease: efficacy of white cell-reduction filters in removing Trypanosoma cruzi from infected blood. Transfusion 1995;35:723-6.